Cas:3600-87-1 2-Amino-1-(2,5-dimethoxyphenyl)ethanol manufacturer & supplier

We serve Chemical Name:2-Amino-1-(2,5-dimethoxyphenyl)ethanol CAS:3600-87-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Amino-1-(2,5-dimethoxyphenyl)ethanol

Chemical Name:2-Amino-1-(2,5-dimethoxyphenyl)ethanol
CAS.NO:3600-87-1
Synonyms:Midodrine Related Compound A;ST 1059 (Desglymidodrine);2-amino-1-(2,5-dimethoxyphenyl)ethan-1-ol;(+/-)-2-amino-1-(2,5-dimethoxyphenyl)ethanol;1-(2′,5′-Dimethoxyphenyl)aminoethanol;1-(2′,5′-dimethoxyphenyl)-2-aminoethanol;de-glymidodrine
Molecular Formula:C10H15NO3
Molecular Weight:197.23100
HS Code:2922509090

Physical and Chemical Properties:
Melting point:146-150ºC dec.
Boiling point:364.3ºC at 760mmHg
Density:N/A
Index of Refraction:1.542
PSA:64.71000
Exact Mass:197.10500
LogP:1.39620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like Midodrine Related Compound A chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,de-glymidodrine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ST 1059 (Desglymidodrine) Use and application,de-glymidodrine technical grade,usp/ep/jp grade.


Related News: The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months. 2-Amino-1-(2,5-dimethoxyphenyl)ethanol manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 2-Amino-1-(2,5-dimethoxyphenyl)ethanol supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 2-Amino-1-(2,5-dimethoxyphenyl)ethanol vendor Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant. 2-Amino-1-(2,5-dimethoxyphenyl)ethanol factory Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).